Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Gross Profit of $262.9 thousand for fiscal year 2025.
Cannabis Bioscience International Holdings, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $262.9K | +29.4% |
| 2024 | $203.2K | -9.0% |
| 2023 | $223.4K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $42.8K | -35.6% | +166.3% |
| August 31, 2025 | $16.1K | -90.6% | -75.8% |
| November 30, 2024 | $66.4K | +36.6% | -61.0% |
| August 31, 2024 | $170.5K | +166.4% | +593.1% |
| February 29, 2024 | $24.6K | -9.3% | -49.4% |
| November 30, 2023 | $48.7K | -35.5% | -24.0% |
| August 31, 2023 | $64.0K | — | +135.9% |
| February 28, 2023 | $27.1K | — | -64.1% |
- Cannabis Bioscience International Holdings, Inc. showed an increase of +29.4% in Gross Profit compared to the prior fiscal year.
- Over the 2023–2025 period, Cannabis Bioscience International Holdings, Inc.’s gross profit has grown by 17.7% (from $223.4 thousand to $262.9 thousand).
- The most recent figure is from Cannabis Bioscience International Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: